Los puntos clave no están disponibles para este artículo en este momento.
The pharmaceutical industry is exposed to severe conditions: while a typical R (2) R and (3) open innovation modes.
Gassmann et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: